|Articles|November 18, 2022
- Pharm Exec E-Books-11-18-2022
- Volume Sponsored eBook
- Issue 6
Investing in Next-Generation Tokenization and Real-World Data to Unlock a More Precise and Complete Patient Journey
Author(s)LexisNexis® Risk Solutions
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Relation Therapeutics Forms $1.7 Billion Multi-Program Collaboration with Novartis Advancing Therapeutics for Atopic Diseases
2
Pfizer Enters Exclusive Collaboration and License Agreement with Yao Pharma for Oral Small-Molecule GLP-1 Agonists
3
Eli Lilly’s Jaypirca Achieves Primary Endpoint in Head-to-Head Phase III Study Against Imbruvica Treating CLL/SLL
4
Carvykti Displays Sustained Remissions in Early Use for Relapsed or Refractory Multiple Myeloma
5
